Benzinga | Aug 6, 2020 04:45PM EDT

Monopar Therapeutics Q2 EPS $(0.14), Reports Cash And Equivalents Of $12.5M As Of Jun. 30

Monopar Therapeutics (NASDAQ:MNPR) reported quarterly losses of $(0.14) per share.